TScan Therapeutics
TCRX
TCRX
25 hedge funds and large institutions have $26.3M invested in TScan Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
41% less capital invested
Capital invested by funds: $44.4M → $26.3M (-$18M)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$560K | |
| 2 | +$445K | |
| 3 | +$210K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$104K |
| 5 |
BlackRock
New York
|
+$57.8K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$654K | |
| 3 | -$219K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$115K |
| 5 |
HF
HRT Financial
New York
|
-$93K |